The DOI matches its Crossref record.
Antimalarial drug resistance: the pace quickens
Abstract
For an infection affecting approximately 5% of the World's population at any time, and killing between one and two million children each year, there are remarkably few drugs available for the treatment of falciparum malaria. Traditionally, antimalarial drug research has been stimulated by wars in tropical malarious areas involving economically-powerful temperate-climate powers. Armies fighting in the tropics lose more soldiers to malaria than bullets (Melville, 1911). The Second World War and the conflict in Vietnam brought us most of the drugs available today. The list is small, and the parasite has not been idle: Plasmodium falciparum has now developed resistance to all of our available drugs. The situation is particularly bad in South-East Asia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Spiroindolones, a Potent Compound Class for the Treatment of Malaria
Rottmann, M., McNamara, C., Yeung, B. K. S., Lee, M. C. S., Zou, B., Russell, B., Seitz, P., Plouffe, D. M., Dharia, N. V., Tan, J., et al. (2010) · Science · doi:10.1126/science.1193225 · Cited by 1,206
Anderson, T. J. C., Haubold, B., Williams, J. T., Estrada-Franco§, J. G., Richardson, L., Mollinedo, R., Bockarie, M., Mokili, J., Mharakurwa, S., French, N., et al. (2000) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026247 · Cited by 779
Quinoline Antimalarials Mechanisms of Action and Resistance and Prospects for New Agents
Foley, M. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00012-6 · Cited by 592
Assessment of the pharmacodynamic properties of antimalarial drugs in vivo
White, N. J. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1413 · Cited by 575
Self-citationIntercontinental Spread of Pyrimethamine-Resistant Malaria
Roper, C., Pearce, R., Nair, S., Sharp, B., Nosten, F., & Anderson, T. (2004) · Science · doi:10.1126/science.1098876 · Cited by 510
Antimalarial drug resistance and combination chemotherapy
White, N. (1999) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.1999.0426 · Cited by 477
Self-citationPyrimethamine–sulfadoxine resistance in Plasmodium falciparum: what next?
Sibley, C. H., Hyde, J. E., Sims, P. F. G., Plowe, C. V., Kublin, J. G., Mberu, E. K., Cowman, A. F., Winstanley, P. A., Watkins, W. M., & Nzila, A. M. (2001) · Trends in Parasitology · doi:10.1016/s1471-4922(01)02085-2 · Cited by 369
Newton, C. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00008-4 · Cited by 348
Su, X.-Z., Kirkman, L. A., Fujioka, H., & Wellems, T. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80447-x · Cited by 347
A Selective Sweep Driven by Pyrimethamine Treatment in Southeast Asian Malaria Parasites
Nair, S. (2003) · Molecular Biology and Evolution · doi:10.1093/molbev/msg162 · Cited by 308
White, N. J., & Olliaro, P. L. (1996) · Parasitology Today · doi:10.1016/0169-4758(96)10055-7 · Cited by 307
Self-citationPharmacokinetics of Quinine, Chloroquine and Amodiaquine: Clinical Implications
Krishna, S., & White, N. J. (1996) · Clinical Pharmacokinetics · doi:10.2165/00003088-199630040-00002 · Cited by 304
Self-citationPrice, R. N., Cassar, C., Brockman, A., Duraisingh, M., van Vugt, M., White, N. J., Nosten, F., & Krishna, S. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.12.2943 · Cited by 279
Self-citationCurrent status of malaria and potential for control
Phillips, R. S. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.1.208-226.2001 · Cited by 266
Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
Price, R., van Vugt, M., Phaipun, L., Luxemburger, C., Simpson, J., McGready, R., ter Kuile, F., Kham, A., Chongsuphajaisiddhi, T., White, N. J., et al. (1999) · The American journal of tropical medicine and hygiene · doi:10.4269/ajtmh.1999.60.547 · Cited by 262
Self-citationPreventing antimalarial drug resistance through combinations
White, N. J. (1998) · Drug Resistance Updates · doi:10.1016/s1368-7646(98)80208-2 · Cited by 259
Self-citationRickards, R. W., Rothschild, J. M., Willis, A. C., de Chazal, N. M., Kirk, J., Kirk, K., Saliba, K. J., & Smith, G. D. (1999) · Tetrahedron · doi:10.1016/s0040-4020(99)00833-9 · Cited by 249
Nzila, A. M., Mberu, E. K., Sulo, J., Dayo, H., Winstanley, P. A., Sibley, C. H., & Watkins, W. M. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.991-996.2000 · Cited by 232
In vivo antimalarial activity of the beta-carboline alkaloid manzamine A
Ang, K. K. H., Holmes, M. J., Higa, T., Hamann, M. T., & Kara, U. A. K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1645-1649.2000 · Cited by 218
McGready, R., Cho, T., Keo, N. K., Thwai, K. L., Villegas, L., Looareesuwan, S., White, N. J., & Nosten, F. (2001) · Clinical Infectious Diseases · doi:10.1086/324349 · Cited by 178
Self-citationMcGready, R., Brockman, A., Cho, T., Cho, D., van Vugt, M., Luxemburger, C., Chongsuphajaisiddhi, T., White, N. J., & Nosten, F. (2000) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(00)90235-9 · Cited by 110
Self-citationRecent advances in antimalarial drug development
Vangapandu, S., Jain, M., Kaur, K., Patil, P., Patel, S. R., & Jain, R. (2007) · Medicinal Research Reviews · doi:10.1002/med.20062 · Cited by 108
LINDSAY, EWALD, SAMUNG, APIWATHNASORN, & NOSTEN (1998) · Medical and Veterinary Entomology · doi:10.1046/j.1365-2915.1998.00115.x · Cited by 41
Kumar, S., Singh, R. K., Sharma, R., Murthy, R. S. R., & Bhardwaj, T. R. (2015) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.09.023 · Cited by 34
Metadata
- Authors
- White, N. J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 1992
- Volume
- 30
- Issue
- 5
- Pages
- 571-585
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2169690281
- Cited by
- 278
- References
- 0
- FWCI
- 10.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.